Neuro-Oncology News

The addition of interferon alfa to temozolomide significantly extended survival among patients with newly diagnosed high-grade gliomas, according to data published in JAMA Network Open.

Tovorafenib monotherapy induced response among approximately two-thirds of patients with recurrent or progressive pediatric low-grade glioma, according to topline data released by the agent’s manufacturer.

The FDA announced several regulatory actions the past few weeks.

Linda H. Malkas, PhD, remembers the day a photograph for a newspaper changed her life.

Jessica Clymer, MD, has been appointed director of pediatric neuro-oncology at Hassenfeld Children’s Hospital at NYU Langone.

Maximal resection of low-grade glioma shortly after diagnosis may lead to longer survival, according to research published in the Journal of Clinical Oncology.

A restrictive opioid prescription protocol of 3 days or less after hospital discharge appeared feasible among a cohort of patients who underwent surgery at a large cancer center, according to study results published in JAMA Oncology.

NEW ORLEANS — Consolidation therapy with high-dose chemotherapy followed by hematopoietic stem cell transplant significantly prolonged PFS among adults with primary central nervous system lymphoma, according to study results.

The FDA announced several regulatory actions the past few weeks.

Certain fungal species in tumors may be associated with worse cancer outcomes, according to a study conducted by researchers at Weill Cornell Medicine and Duke University and published in the journal Cell.